Huons

Huons is a South Korean healthcare company specializing in pharmaceuticals, including generics, sterile products, ophthalmology, dermatology, and aesthetics. As a KOSDAQ-listed holding company, it manufactures hospital-focused formulations and health functional foods, also providing contract manufacturing services leveraging its sterile production expertise. Its diverse product portfolio primarily serves hospitals, institutions, and wholesalers across South Korea. A key commercial success was its 'Menolacto' lactobacillus product, which surpassed 100 billion won in sales in 2023. Recent strategic developments include the planned establishment of Huons N from a health functional food merger in May 2025, the incorporation of its PanGen subsidiary in December 2024, and the completion of the Gwacheon Dong-Am R&D Center in November 2024. The company was founded on July 30, 1965, by Yoon Myeong Yong.